Health In Tech, Inc. (HIT)
NASDAQ: HIT · Real-Time Price · USD
1.490
-0.010 (-0.67%)
At close: Apr 28, 2026, 4:00 PM EDT
1.492
+0.002 (0.12%)
After-hours: Apr 28, 2026, 7:25 PM EDT
Health In Tech Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Health In Tech stock have an average target of 3.25, with a low estimate of 2.50 and a high estimate of 4.00. The average target predicts an increase of 118.12% from the current stock price of 1.49.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Health In Tech stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|
| Strong Buy | 1 | 1 | 2 |
| Buy | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 |
| Total | 1 | 1 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +168.46% | Apr 20, 2026 |
| Maxim Group | Maxim Group | Strong Buy Initiates $2.5 | Strong Buy | Initiates | $2.5 | +67.79% | Jun 26, 2025 |
Financial Forecast
Revenue This Year
46.99M
from 33.33M
Increased by 41.00%
Revenue Next Year
79.71M
from 46.99M
Increased by 69.63%
EPS This Year
-0.01
from 0.02
EPS Next Year
0.17
from -0.01
Revenue Forecast
| Revenue | 2026 | 2027 |
|---|---|---|
| High | 49.0M | 84.1M |
| Avg | 47.0M | 79.7M |
| Low | 45.5M | 76.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 |
|---|---|---|
| High | 47.0% | 79.0% |
| Avg | 41.0% | 69.6% |
| Low | 36.4% | 62.1% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | - | 0.18 |
| Avg | -0.01 | 0.17 |
| Low | -0.01 | 0.17 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.